PRTN3 and rheumatoid arthritis: ACPA targets citrullinated proteins and peptides, which are significant markers in RA (3, 4), aiding in classifying RA into seropositive (ACPA+ and/or RF+) and seronegative (ACPA− and RF−) types (5).